Vimedimex Medi Pharma JSC
Vimedimex Medi-Pharma Joint Stock Company engages in the pharmaceutical distribution business in Vietnam. The company provides imported drugs, domestic medicines, medical supplies, family medical equipment, healthcare instruments, and functional foods; and leasing of office buildings and warehouses. It also offers prescription drugs, supplements, medical equipment, cosmetics, and mother and baby … Read more
Market Cap & Net Worth: Vimedimex Medi Pharma JSC (VMD)
Vimedimex Medi Pharma JSC (VN:VMD) has a market capitalization of $6.35K (₫161.35 Million) as of March 19, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #28829 globally and #244 in its home market, demonstrating a -21.26% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vimedimex Medi Pharma JSC's stock price ₫16300.00 by its total outstanding shares 9899 (9.90K).
Vimedimex Medi Pharma JSC Market Cap History: 2015 to 2025
Vimedimex Medi Pharma JSC's market capitalization history from 2015 to 2025. Data shows growth from $6.22K to $6.35K (0.73% CAGR).
Vimedimex Medi Pharma JSC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vimedimex Medi Pharma JSC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VMD by Market Capitalization
Companies near Vimedimex Medi Pharma JSC in the global market cap rankings as of March 19, 2026.
Key companies related to Vimedimex Medi Pharma JSC by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Vimedimex Medi Pharma JSC Historical Marketcap From 2015 to 2025
Between 2015 and today, Vimedimex Medi Pharma JSC's market cap moved from $6.22K to $ 6.35K, with a yearly change of 0.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ₫6.35K | -1.21% |
| 2024 | ₫6.43K | -2.94% |
| 2023 | ₫6.62K | -10.44% |
| 2022 | ₫7.40K | -33.74% |
| 2021 | ₫11.16K | +77.77% |
| 2020 | ₫6.28K | -10.02% |
| 2019 | ₫6.98K | +25.99% |
| 2018 | ₫5.54K | -9.70% |
| 2017 | ₫6.13K | -14.79% |
| 2016 | ₫7.20K | +15.76% |
| 2015 | ₫6.22K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Vimedimex Medi Pharma JSC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.35K USD |
| MoneyControl | $6.35K USD |
| MarketWatch | $6.35K USD |
| marketcap.company | $6.35K USD |
| Reuters | $6.35K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.